Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Gastrointestinal Cancer Research : GCR|April 11, 2009
Update on targeted agents for adjuvant treatment of colon cancer in 2006Aimery de Gramont, Annette K Larsen, Christophe Tournigand, et al.
Current Oncology Reports|April 26, 2005
First-line therapy for advanced colorectal cancerAimery de Gramont, Christophe Tournigand, Christophe Louvet, et al.
Seminars in Oncology|December 21, 2006
Targeted agents for adjuvant therapy of colon cancerAimery de Gramont, Christophe Tournigand, Thierry André, et al.
Bulletin Du Cancer|August 8, 2016
[Are cancer outpatients ready for e-medicine?]Emmanuelle Kempf, Audrey Prévost, Benoit Rousseau, et al.
Gastroenterologie Clinique Et Biologique|August 4, 2006
Assessment of management practices for colonic cancer in the Paris metropolitan area in 2002Lina Silvéra, Gilles Galula, Emmanuel Tiret, et al.
Gynecologic Oncology|September 6, 2006
Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factorsPierre Blanchard, Anne Plantade, Cécile Pagès, et al.
Gastroenterologie Clinique Et Biologique|March 27, 2003
[Radiofrequency ablation of an unresectable abdominal tumor]Alain Sézeur, Sylvie Fritsch, Christophe Louvet, et al.
BMC Cancer|October 8, 2015
A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trialJean-Baptiste Bachet, Benoist Chibaudel, Franck Bonnetain, et al.
Clinical Colorectal Cancer|April 10, 2010
Comparison of the levogyre and dextro-levogyre forms of leucovorin in a phase III trial of bimonthly LV5FU2 versus monthly 5-fluorouracil and high-dose leucovorin for patients with stage II and III colon cancer (GERCOR C96.1)Isabelle Baumgaertner, Emmanuel Quinaux, Ahmed Khalil, et al.
Clinical Colorectal Cancer|April 19, 2020
Understanding the Prognostic Value of Primary Tumor Location and KRAS in Metastatic Colorectal Cancer: A Post Hoc Analysis of the OPTIMOX3 DREAM Phase III StudyBenoist Chibaudel, Thierry André, Christophe Tournigand, et al.
Pageof 14